Emilia Szkiela

Senior Associate
Attorney-at-law

Corporate law

Specializes in corporate law. Advises companies on their day-to-day operations. Carries out domestic and cross-border reorganizations of commercial law companies.

Emilia Szkiela

Languages: Emilia Szkiela

BIO

Emilia joined our firm in 2022.

Emilia specializes in corporate and commercial law. For years, she has been advising companies in their day-to-day operations, in particular supporting entities in the conduct of their corporate affairs, working with their governing bodies. She has extensive experience in carrying out reorganizations of companies, also on an international scale. Assists in due diligence studies.

Emilia Szkiela

Experience

Selected projects

  • Advised SAPERE Holding, a Polish family-owned investment group, on the acquisition of 100% of the shares in K2 Group, a manufacturer of automotive chemicals and car care products operating in more than 90 countries
  • Advised CenterMed on the acquisition of NZOZ Partner, a healthcare provider operating three medical facilities in Kielce offering primary healthcare, outpatient specialist care and rehabilitation services
  • Advised LUX MED on the acquisition of 100% of the shares in TMS Diagnostyka, a medical imaging company
  • Advised CenterMed on the acquisition of the Avimed Group, a healthcare provider operating in the Silesia region
  • Advised LUX MED on the acquisition of the Mental Path network of seven mental health centres operating in five cities across Poland
  • Advised the co-founders of Surfer on a complex M&A transaction involving a number of separate issues related to their relationship with France’s Positive Group
  • Advised the ArKa family foundation on the sale of a 75% stake in Centrum Medyczne Med-Gastr, a gastroenterology clinic, to private equity fund Tar Heel Capital
  • Advised Szopex sp. z o.o., an operator of sports retail stores and e-commerce platforms, on the sale of a 75% stake to Modivo, part of CCC Group, for PLN 27.8 million
  • Sale of  SoftwareMill company to VirtusLab

News
& Insights

18.06.2026

GESSEL advised SAPERE Holding on the acquisition of K2 Group

GESSEL advised SAPERE Holding on its acquisition of 100% of the shares in K2 Group, the owner of the K2 brand, one of Poland’s best-known manufacturers of automotive che...

Case studies
GESSEL advised SAPERE Holding on the acquisition of K2 Group

20.05.2026

GESSEL advised CenterMed on the acquisition of NZOZ Partner

GESSEL advised CenterMed, a Polish medical group developing a network of healthcare facilities, on the acquisition of NZOZ Partner sp. z o.o., a healthcare services prov...

Case studies
GESSEL advised CenterMed on the acquisition of NZOZ Partner

21.04.2026

GESSEL advises Lux Med on acquisition of TMS Diagnostyka

GESSEL advised Lux Med sp. z o.o., a leading private healthcare provider in Poland, on the acquisition of 100% of the shares in TMS Diagnostyka sp. z o.o., a Poland base...

Case studies
GESSEL advises Lux Med on acquisition of TMS Diagnostyka

16.01.2026

GESSEL’s dedicated Healthcare M&A team advised on ten sectoral deals in 2025

In 2025, GESSEL successfully advised on ten mergers and acquisitions transactions in the healthcare sector. The mandates covered advisory services on both the sell side ...

News
GESSEL’s dedicated Healthcare M&A team advised on ten sectoral deals in 2025
Show more

Education and achievements

Emilia Szkiela
  • Legal studies at the Faculty of Law and Administration of the University of Łódź (2018)
  • Legal studies completed with a Master of Law (LL.M.) degree awarded by Maastricht University with a specialization in Business in Law (2022)
  • Admitted to practice as an attorney (2022)